Treatment advances in psoriatic arthritis.

Eric M. Ruderman*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Treatment of psoriatic arthritis, like the treatment of rheumatoid arthritis, now commonly includes the use of inhibitors of tumor necrosis factor in addition to traditional synthetic disease-modifying antirheumatic drugs. This paper examines the most recent data from therapeutic trials in psoriatic arthritis, with particular emphasis on the effectiveness of the tumor necrosis factor inhibitors. Recent data on potential future therapies is discussed as well, along with data on the mechanisms of current therapies that may have relevance for future treatment approaches.

Original languageEnglish (US)
Pages (from-to)313-318
Number of pages6
JournalCurrent rheumatology reports
Volume7
Issue number4
DOIs
StatePublished - Aug 2005

ASJC Scopus subject areas

  • Rheumatology

Fingerprint Dive into the research topics of 'Treatment advances in psoriatic arthritis.'. Together they form a unique fingerprint.

Cite this